
    
      Study duration per participant is approximately 103 days including a screening period up to
      21 days before first dose, 4 periods of dosing and pharmacokinetic (PK) sampling each lasting
      7 days, a washout period of 8-21 days between dosing, and an end of study visit 10-15 days
      after the last dose.
    
  